Dipna Pharmachem Limited (BOM:543594)
4.280
+0.130 (3.13%)
At close: Oct 5, 2026
Dipna Pharmachem Market Cap
Dipna Pharmachem has a market cap or net worth of 112.52 million as of October 5, 2026. Its market cap has decreased by -77.50% in one year.
Market Cap
112.52M
Enterprise Value
232.71M
Revenue
1.29B
Ranking
n/a
PE Ratio
4.28
Stock Price
4.28
ChartMarket Cap Chart
Since September 8, 2022, Dipna Pharmachem's market cap has decreased from 399.80M to 112.52M, a decrease of -71.86%. That is a compound annual growth rate of -26.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 112.52M | -74.67% |
| Dec 30, 2025 | 444.29M | 28.22% |
| Dec 31, 2024 | 346.49M | 171.80% |
| Dec 29, 2023 | 127.48M | -47.79% |
| Dec 30, 2022 | 244.19M | -38.92% |
| Sep 8, 2022 | 399.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Goldline Pharmaceutical | 297.31M |
| Medistep Healthcare | 291.30M |
| Medico Intercontinental | 251.90M |
| Pentokey Organy (India) | 207.44M |
| Centuple Global | 179.63M |
| Zenlabs Ethica | 172.52M |
| Muller & Phipps (India) | 125.19M |
| Adline Chem Lab | 87.98M |